GoodRx appoints Wendy Barnes as CEO and President, effective Jan 1, 2025

GoodRx Holdings, Inc.

Wendy Barnes named CEO/President, succeeding interim CEO Scott Wagner; also elected Class I director.
Base salary of $825,000, target bonus 100% of salary, and a $550,000 signing bonus.
Equity grants: $9M RSU, $9M option, and $2M additional RSU, vesting over time.
Severance: 12-18 months base salary plus COBRA for 18 months, with accelerated vesting on change of control.
Barnes previously CEO of RxBenefits and President of Express Scripts; holds biochemistry degree.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.